Ascendis Pharma A/S - ADR Live Stock Price Today, Share Analysis and Chart

Name: Ascendis Pharma A/S - ADR: Is Infosys Ltd. worth buying?
Item: Ascendis Pharma A/S - ADR
Rating: 1.39208325
Author: Trendlyne DVM scores

about

Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, a...

166.78 3.46 (2.12%)

50.13% Gain from 52W Low

599.7K

XNAS Volume

XNAS 30 Jul, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

4.3 / 100

Technically Neutral

51.4 / 100

232

1Yr Price target upside is 39%

16 analysts

Ascendis Pharma A/S - ADR Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..